Algert Global LLC Arcus Biosciences, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Algert Global LLC holds 112,847 shares of RCUS stock, worth $1.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

112,847

Previous 76,257 47.98%

Holding current value

$1.66 Million

Previous $1.16 Million 48.58%

% of portfolio

0.05%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.69 - $18.01 $500,917 - $658,985	36,590 Added 47.98%	112,847 $1.73 Million
Q2 2024 Aug 14, 2024	BUY	$14.59 - $18.48 $262,605 - $332,621	17,999 Added 30.9%	76,257 $1.16 Million
Q1 2024 May 14, 2024	SELL	$14.83 - $20.18 $337,975 - $459,902	-22,790 Reduced 28.12%	58,258 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$13.43 - $19.63 $121,272 - $177,258	9,030 Added 12.54%	81,048 $1.55 Million
Q3 2023 Nov 13, 2023	BUY	$17.62 - $23.54 $173,204 - $231,398	9,830 Added 15.81%	72,018 $1.29 Million
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $914,699 - $1.19 Million	-53,901 Reduced 46.43%	62,188 $1.26 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $1.64 Million - $2.38 Million	102,706 Added 767.44%	116,089 $2.12 Million
Q4 2022 Feb 13, 2023	SELL	$19.7 - $35.71 $451,327 - $818,116	-22,910 Reduced 63.13%	13,383 $277,000
Q3 2022 Nov 15, 2022	BUY	$23.23 - $30.07 $315,997 - $409,042	13,603 Added 59.95%	36,293 $949,000
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $390,948 - $856,093	22,690 New	22,690 $575,000
Q2 2020 Aug 12, 2020	SELL	$13.97 - $36.56 $354,530 - $927,819	-25,378 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$8.78 - $19.28 $671,389 - $1.47 Million	-76,468 Reduced 75.08%	25,378 $352,000
Q4 2019 Feb 18, 2020	BUY	$7.33 - $10.79 $631,670 - $929,839	86,176 Added 549.94%	101,846 $1.03 Million
Q3 2019 Nov 14, 2019	BUY	$6.44 - $10.18 $100,914 - $159,520	15,670 New	15,670 $143,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.06B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Arcus Biosciences, Inc. Transaction History